Epilepsy in Pregnancy: Optimization of Maternal-Fetal Outcomes

Epilepsy is a chronic neurological disorder characterized by a predisposition to recurrent, unprovoked epileptic seizures resulting from abnormal, excessive, or synchronous neuronal activity in the brain. Pregnancy in women with epilepsy requires multidisciplinary management because physiological changes during gestation may alter antiseizure medication (ASM) pharmacokinetics, affect seizure control, and influence maternal and fetal outcomes. Although most women with epilepsy experience favorable pregnancy outcomes, the risks of congenital malformations, fetal growth restriction, maternal injury, and pregnancy-related complications vary according to seizure control, the specific medication used, dosage, and the presence of comorbidities. Optimal management includes preconception counseling, individualized ASM selection, folic acid supplementation, regular neurological and obstetric assessment, appropriate fetal surveillance, and careful intrapartum and postpartum planning. Epilepsy alone is not an indication for cesarean delivery, and breastfeeding is generally encouraged with appropriate medication-specific counseling. This review summarizes the principal clinical considerations in the management of epilepsy during pregnancy, labor, delivery, and the postpartum period.

Authors

Publication Details

Journal
International Journal of Science and Research (IJSR)
Published
2026-11-14
DOI
https://doi.org/10.21275/sr261104110623
Primary Topic
Pharmacological Effects and Toxicity Studies
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Epilepsy in Pregnancy: Optimization of Maternal-Fetal Outcomes

Weeda Noori
International Journal of Science and Research (IJSR)
Pharmacological Effects and Toxicity Studies
article

Epilepsy in Pregnancy: Optimization of Maternal-Fetal Outcomes

Weeda Noori
article en

Abstract

Epilepsy is a chronic neurological disorder characterized by a predisposition to recurrent, unprovoked epileptic seizures resulting from abnormal, excessive, or synchronous neuronal activity in the brain. Pregnancy in women with epilepsy requires multidisciplinary management because physiological changes during gestation may alter antiseizure medication (ASM) pharmacokinetics, affect seizure control, and influence maternal and fetal outcomes. Although most women with epilepsy experience favorable pregnancy outcomes, the risks of congenital malformations, fetal growth restriction, maternal injury, and pregnancy-related complications vary according to seizure control, the specific medication used, dosage, and the presence of comorbidities. Optimal management includes preconception counseling, individualized ASM selection, folic acid supplementation, regular neurological and obstetric assessment, appropriate fetal surveillance, and careful intrapartum and postpartum planning. Epilepsy alone is not an indication for cesarean delivery, and breastfeeding is generally encouraged with appropriate medication-specific counseling. This review summarizes the principal clinical considerations in the management of epilepsy during pregnancy, labor, delivery, and the postpartum period.

International Journal of Science and Research (IJSR)
Pharmacological Effects and Toxicity Studies
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon